Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation

Details for Australian Patent Application No. 2005243482 (hide)

Owner Vasopharm GmbH

Inventors Scheurer, Peter; Wingler, Kirstin; Schinzel, Reinhard; Tegtmeier, Frank; Schmidt, Harald; Walter, Ulrich

Agent Watermark

Pub. Number AU-B-2005243482

PCT Pub. Number WO2005/111041

Priority 60/571,994 18.05.04 US; 04011831.7 18.05.04 EP

Filing date 13 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 16 December 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/111041 Priority application(s): WO2005/111041

10 May 2007 Change of Name(s) of Applicant(s), Section 104

  Vasopharm Biotech GmbH The name of the applicant has been changed to Vasopharm GmbH

16 December 2010 Application Accepted

  Published as AU-B-2005243482

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243488-Vaccine comprising an attenuated pestivirus

2005243481-Process for producing polypropylene film